MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.77
+4.79%Next report
Analyst consensus
- Next report date
- Sep 18, 2026
- EPS estimate
- -$1.35
- Revenue estimate
- —
Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$1.34
- EPS estimate
- -$0.96
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -752.6%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $32
- PT range
- $13 – $46
- Analysts
- 8
6 Buy2 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 3, 2026